Prevalence and Health Care Disparities of Retinal Conditions
JAMA Ophthalmology 10.1001/jamaophthalmol.2026.0319March 19, 2026 at 11:00 AM EDT
What is the prevalence of age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic macular edema (DME), and retinal vein occlusion (RVO) in the US?In this meta-analysis, the estimated 2022 US age-standardized prevalence (per 100 000 people) was 5677 for AMD, 2710 for DR, 317 for DME, and 214 for RVO. AMD and RVO prevalence was higher in White individuals (vs Black or Hispanic individuals); DR and DME prevalence was higher in Black and Hispanic individuals (vs White individuals).The estimated prevalence of these retinal conditions is substantial, highlighting a large health care burden; understanding the disparities in prevalence may aid in future resource planning.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.